Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.

[1]  Michael,et al.  Small cell lung cancer: have we made any progress over the last 25 years? , 2007, The oncologist.

[2]  G. Giaccone,et al.  Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Bottomley,et al.  Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Giaccone,et al.  Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H J Tagnon,et al.  The European Organization for Research on Treatment of Cancer. , 1986, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  N. Hanna.  Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study) , 2007 .

[7]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[9]  S. Kaasa,et al.  The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. , 1994, European journal of cancer.